The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells

Katrin Mestermann1, Theodoros Giavridis2, Justus Weber1, Julian Rydzek1, Silke Frenz1, Thomas Nerreter1, Andreas Mades1, Michel Sadelain2, Hermann Einsele1, Michael Hudecek1
1Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, 97080 Würzburg, Germany
2Center for Cell Engineering and Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Tóm tắt

Dasatinib is a pharmacologic switch for CARs that enables physicians to control CAR T cell function in real time.

Từ khóa


Tài liệu tham khảo

10.1056/NEJMra1706169

10.1038/nature22395

10.1126/scitranslmed.aaf8621

10.1056/NEJMoa1709919

10.1038/nrclinonc.2017.148

10.1182/blood-2017-06-793141

10.1038/s41591-018-0041-7

10.1038/s41591-018-0036-4

10.1371/journal.pone.0144787

10.1016/j.ymthe.2018.11.015

10.1158/0008-5472.CAN-05-4187

10.1016/j.clim.2008.02.006

10.1124/dmd.107.018267

10.1172/JCI84813

10.1089/10430340460732463

10.1182/blood-2004-11-4564

10.1126/science.276.5319.1719

International Centre for Kinase Profiling Kinase Profiling Inhibitor Database (2017); www.kinase-screen.mrc.ac.uk/kinase-inhibitors.

10.1007/s00280-007-0478-8

10.1007/s00262-007-0298-z

10.1038/nature22367

10.1038/nature21405

10.1158/2326-6066.CIR-14-0127

10.1038/s41591-018-0290-5

10.1074/jbc.273.52.34970

10.1182/blood-2011-07-366419